Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Feasibility Study of Take-Home LAAM Medication - 3 Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Feasibility Study of Take-Home LAAM Medication - 3 conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Feasibility Study of Take-Home LAAM Medication - 3 Clinical research trials and Feasibility Study of Take-Home LAAM Medication - 3 health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Feasibility Study of Take-Home LAAM Medication - 3. Feasibility Study of Take-Home LAAM Medication - 3 Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Feasibility Study of Take-Home LAAM Medication - 3 clinical trial. Participants oftentimes recieve the most expert healthcare available for their Feasibility Study of Take-Home LAAM Medication - 3 condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "F" Clinical Trials Conditions > Feasibility Study of Take-Home LAAM Medication - 3

Feasibility Study of Take-Home LAAM Medication - 3



Feasibility Study of Take-Home LAAM Medication - 3

For Condition: Opioid-Related Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: Test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?
Details: 1-Year study, participant will be randomly assigned to one of two groups: One will have the opportunity to earn take-home doses by turning in a designated number of clean urines. Two will not have the opportunity to earn take-home doses. Clinic visits three times per week. Urine sample given at each visit.
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Uncontrolled
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: meets DSM-IV criteria for opiate dependence. M/F, 18 years or older. Certified for LAAm treatment by a physician. Able to understand english. Willing to provide names, addresses, and numbers of 3 relatives who can aid in patient location for follow-up visits. Exclusion Criteria: Hypertensive to LAAM. Pregnant or nursing women. Female of childbearing potential who refuses to use an acceptable form of birth control. Clinically significant abnormality in hematology, blood work, or UA, ETOH and/or sedative/hypnotic dependence according to DSM-IV criteria. Medical or psychiatric illness which would jeopardize safe study participation.
Total Enrollment: 0

Location and Contact Information:

Overall Study Official:
WalterLing,  Principal Investigator,  Friends Research Institute

Friends Research Institute
Los Angeles,  California,  90025
United States
 


Additional Information:
Study ID Numbers:  NIDA-09260-3;  P50-09260-3
Study Start Date: March 1995
Record last reviewed: March 1995
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000300

Other Opioid-Related Disorders Studies:
1. Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

2. Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

3. Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

4. Alternate-Day Buprenorphine Administration. Phase VI - 7

5. Buprenorphine Detoxification - BBDVI - 19

Related Studies:

Other Opioid-Related Disorders Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials

Feasibility Study of Take-Home LAAM Medication - 3
Modify your Search

  Other Opioid-Related Disorders Clinical Trials
  Other California Clinical Trials
  Other Los Angeles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103